Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
Clinical trial NCT00032279 · UNKNOWN
Trial details
- NCT number
- NCT00032279
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.